2. Epigenetics Protein Tyrosine Kinase/RTK JAK/STAT Signaling Stem Cell/Wnt Apoptosis
  3. JAK Apoptosis
  4. Tofacitinib Prodrug-1

Tofacitinib Prodrug-1  (Synonyms: 托法替尼前药)

目录号: HY-145829
产品使用指南

摩尔计算器

Tofacitinib Prodrug-1 是减轻托法替尼 (Tofacitinib) 全身性不良反应的口服有效前药。Tofacitinib Prodrug-1 能在小鼠模型有效减轻恶唑酮诱导的结肠炎，具有低毒性，是研究溃疡性结肠炎的潜在候选活性分子。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Tofacitinib Prodrug-1 Chemical Structure

Tofacitinib Prodrug-1 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

Tofacitinib Prodrug-1 相关抗体

Top Publications Citing Use of Products

查看 JAK 亚型特异性产品:

查看所有亚型
JAK1 JAK2 JAK3 Tyk2 JAK

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Tofacitinib precursor-1 is an effective and oral active precursor to mitigate the systemic adverse effects of Tofacitinib. Tofacitinib precursor-1 can effectively attenuate the oxazolone-induced colitis in mice model with low toxicity. Tofacitinib precursor-1 is a potential drug candidate for the research of ulcerative colitis[1].

体外研究
(In Vitro)

Tofacitinib Prodrug-1 (compound 20g) (1 mM; 12 hours at 37 °C) is not obviously degraded from 0 to 12 hours in simulated gastric and intestinal fluid[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Tofacitinib Prodrug-1 相关抗体:
体内研究
(In Vivo)

Tofacitinib Prodrug-1 (22.5 mg/kg; p.o.) can decrease the systemic exposure of tofacitinib by releasing the parent drug Tofacitinib into the circulation slowly[1].
Tofacitinib Prodrug-1 (22.5 mg/kg; p.o.) can increase intestinal exposure to improve the therapeutic effect of Tofacitinib[1].
Tofacitinib Prodrug-1 (1.5 mg/kg; p.o.; twice daily, for 4 days) can effectively attenuate the oxazolone-induced colitis in mice[1].
Tofacitinib Prodrug-1 (1.5 mg/kg; i.g.; twice daily, for 4 days) has no apparent influence on systemic immunosuppression in normal mice, which could decrease the risk of infection associated with Tofacitinib[1].
Tofacitinib Prodrug-1 (2000 mg/kg; i.g.; single) has low toxicity and was tolerated at an oral dose of 2000 mg/kg, and no significant change was observed in biochemical parameters and organ indexes[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male SD rats (5-6 weeks, 220-250 g, n=6) (pharmacokinetic)[1]
Dosage: 22.5 mg/kg
Administration: p.o.; blood were taken at 1, 2, 4, 6, 8, 12, 14, and 20 hours
Result: Decreased the systemic exposure of tofacitinib by releasing the parent drug tofacitinib into the circulation slowly.
Animal Model: Male BALB/c mice (5-6 weeks, 25-30 g, n = 6)[1]
Dosage: 22.5 mg/kg
Administration: p.o.; blood and intestinal tissues were taken at 0.5, 1, 2, 3, 4, 6, 9, and 12 hours
Result: Increased intestinal exposure to improve the therapeutic effect of tofacitinib.
Animal Model: Male BALB/c mice (5-6 weeks, 25-28 g, n=7-9)[1]
Dosage: 1.5 mg/kg
Administration: p.o.; twice daily, for 4 days
Result: Tofacitinib Prodrug-1 could effectively attenuate the oxazolone-induced colitis in mice.
Animal Model: Male BALB/c mice (5-6 weeks, 25-28 g, n = 10)[1]
Dosage: 1.5 mg/kg
Administration: i.g.; twice daily, for 4 days
Result: Had no apparent influence on systemic immunosuppression in normal mice, which could decrease the risk of infection associated with tofacitinib.
Animal Model: Kunming mice (18-22 g; n = 10)[1]
Dosage: 2000 mg/kg
Administration: i.g.; single
Result: Had low toxicity and was tolerated at an oral dose of 2000 mg/kg, and no significant change was observed in biochemical parameters and organ indexes.
分子量

759.21

Formula

C36H39ClN10O7
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

Tofacitinib Prodrug-1 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Tofacitinib Prodrug-1Tofacitinib Prodrug1Tofacitinib Prodrug 1JAKApoptosisJanus kinaseTofacitinibProdrugUlcerative colitisInflammationSystemic adverse effectsOralInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
Tofacitinib Prodrug-1
目录号：
HY-145829
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z